Market Value509,321,573
Total Holdings44
File Date2023-05-15
Original Filing (Click here)

All hedge funds or institutions that manage over $100M are required by the SEC to file quarterly reports on their holdings. These reports are called 13F reports. However, the filings are required the following quarter from the reporting period, which means that by the time the filing is made (and we see them), the information could be five months old.

For funds with long term positions that make few trades, the holdings might closely resemble their current holdings, even after several months. However, for funds that have high turnover, the holdings data we see might differ significantly from their current holdings. Institutions are required to report CALL and PUT options, and those positions are identified in the table. However, they are not required to report short positions.

Click the link icon to see the full transaction history.

Upgrade to unlock premium data and export to Excel .

Security Imputed
Share Price
Prev
Shares
Current
Shares
Change
(Percent)
Prev Value
(USD x1000)
Current Value
(USD x1000)
Change
(Percent)
DAWN / Day One Biopharmaceuticals, Inc.
ABOS / Acumen Pharmaceuticals, Inc.
VKTX / Viking Therapeutics, Inc.
VKTX / Viking Therapeutics, Inc. Put
ITCI / Intra-Cellular Therapies, Inc.
/ Avalo Therapeutics Inc
VERV / Verve Therapeutics, Inc.
CINC / CinCor Pharma Inc
ERAS / Erasca, Inc.
AVTE / Aerovate Therapeutics, Inc.
SLDB / Solid Biosciences Inc.
ANAB / AnaptysBio, Inc.
IMUX / Immunic, Inc.
JAZZ / Jazz Pharmaceuticals plc
PNT / POINT Biopharma Global Inc.
ALKS / Alkermes plc
GRCL / Gracell Biotechnologies Inc. - Depositary Receipt (Common Stock)
PCVX / Vaxcyte, Inc.
AMLX / Amylyx Pharmaceuticals, Inc.
DTIL / Precision BioSciences, Inc.
LRMR / Larimar Therapeutics, Inc.
RCKT / Rocket Pharmaceuticals, Inc. Call
ICPT / Intercept Pharmaceuticals Inc
TVTX / Travere Therapeutics, Inc.
/ VENTYX BIOSCIENCES INC
OPTN / OptiNose, Inc.
MLTX / MoonLake Immunotherapeutics
HRTX / Heron Therapeutics, Inc.
ALPN / Alpine Immune Sciences, Inc.
PRAX / Praxis Precision Medicines, Inc.
KMPH / Zevra Therapeutics Inc
RARE / Ultragenyx Pharmaceutical Inc.
MRTX / Mirati Therapeutics, Inc.
ALBO / Albireo Pharma Inc
EOLS / Evolus, Inc.
RLAY / Relay Therapeutics, Inc.
SGEN / Seagen Inc
NVCR / NovoCure Limited Put
CBAY / CymaBay Therapeutics, Inc.
GBIO / Generation Bio Co.
RPHM / Reneo Pharmaceuticals, Inc.
PLRX / Pliant Therapeutics, Inc.
MLYS / Mineralys Therapeutics, Inc.
ETNB / 89bio, Inc.
PTCT / PTC Therapeutics, Inc.
ISEE / IVERIC bio Inc
RYTM / Rhythm Pharmaceuticals, Inc.
RAPT / RAPT Therapeutics, Inc.
IMCR / Immunocore Holdings plc - Depositary Receipt (Common Stock)
URGN / UroGen Pharma Ltd.
SRPT / Sarepta Therapeutics, Inc.
XENE / Xenon Pharmaceuticals Inc.
FOLD / Amicus Therapeutics, Inc.
ACRS / Aclaris Therapeutics, Inc. Call
ACRS / Aclaris Therapeutics, Inc.
KALV / KalVista Pharmaceuticals, Inc.
CYTK / Cytokinetics, Incorporated
ACLX / Arcellx, Inc.